Scientists test new drug duo to reawaken immune system against stubborn tumors
Disease control
Not yet recruiting
This early-stage study is testing a new combination of two drugs for people with advanced solid tumors that have stopped responding to standard immunotherapy. The goal is to find the safest and most effective dose of the drug 5-Azacitidine when added to a patient's current immuno…
Phase: PHASE1 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated Mar 03, 2026 14:07 UTC